TA664 for liraglutide 3.0 mg) recommend considering GLP-1 agonists for adults with a BMI of 35 kg/m or more (or 32.5 kg/m or more for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family backgrounds), or a BMI of 30-34.9 kg/m with at least one weight-related comorbidity
Its a rare optic nerve injury sometimes described as a stroke of the eye, which can cause sudden, irreversible vision loss
Hu J, Zhang Q, Ren X, Sun Z, Quan Q (2015) Efficacy and safety of acetylcysteine in non-acetaminophen acute liver failure: a meta-analysis of prospective clinical trials
A protocol for a randomised, double-blind, placebo-controlled study of the effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes (The LIVE Study)